SGX Market Updates

Singapore Banks Begin Reporting 1H22 Results


28 July 2022

  • This year the trio of DBS, UOB and OCBC have contributed more than 25% of the average daily turnover of the Singapore stock market, while averaging a 3% year-to-date total return following the 25% average total return in 2021. Institutions have also been net sellers of the trio in the 2022 year-to-date, following on from net buying in 2021.

  • The trio are scheduled to report 1H22 results, with UOB reporting Fri 29 July , OCBC on Wed 3 Aug, and DBS on Thu 4 Aug – all prior to market open.

  • The trio’s combined NII has generated consecutive q-o-q gains for the past six quarters from 4Q20 through to 1Q22. Key details with the reports that the market will be looking for include the magnitude of NIM expansion, non-interest income and also credit costs. During 1H22, Singapore’s compounded 1M SORA gained close to 80 bps.

DBS, UOB, OCBC Average 3% Year-To-Date Total Returns, Outperforming 3% Decline For Global Peers

In the 2022 year-to-date, DBS (SGX:D05), UOB (SGX:U11) and OCBC (SGX:O39) have ranked as the most traded Singapore stocks, contributing 27% of the day-to-day turnover of all stocks listed for trading in Singapore.

During the year, the trio averaged a 3% total return, in contrast to the top quartile of global bank stocks by market value which have declined 3% in S$ terms. Following S$1.7 billion of combined net institutional inflows in 2021, the trio all continued to attract net institutional inflows in the first two months of 2022, before global growth concerns weighed the global sector, which has seen the trio draw just over S$950 million of net institutional outflows in the 2022 year through to 27 July. Retail investors, on the other hand, net bought slightly over S$1.32 billion of the trio in the 2022 year-to-date. The individual performances are tabled below.

2022 YTD
Average Daily
Market Cap
2022 YTD
YTD Total
2021 Net
2021 Total
DBS D05 156 81 -687 -1 1,172 35 1.4 4.4
UOB U11 101 47 -262 6 451 24 1.1 4.3
OCBC O39 88 52 -2 4 125 17 1.0 4.6
Total 345 180 -951 1,748
Average 3 25 1.2 4.4

Source: SGX, Bloomberg, Refinitiv (Data as of 27 July 2022)

Pending 1H22 Financial Results

The 3 Singapore banks are scheduled to report 1H22 results, with UOB reporting prior to the Fri 29 July open, OCBC reporting prior to the Wed 3 Aug open, and DBS reporting prior to the Thu 4 Aug open (Earnings Calendar). Key numbers within the reports that the market will be looking at include the magnitude of net interest margin (NIM) expansion, non-interest income and also credit costs. NIMs will be largely determined by the average rate paid on the liabilities versus with the average rate received on the assets of the banks and the compounded 1M SORA has moved from 21 bps at the end of 2021, to 99 bps at the end of June 2022.

For 1Q22, the combined Net Interest Income (NII) for the three banks was S$5.38 billion, up S$70 million from S$5.31 billion in 4Q21. The combined NII of the trio has seen q-o-q gains for the past six consecutive quarters from 4Q20 through to 1Q22.

Aside from the impact of NIMs on NII, NII is also driven by the size of bank loan books, which can obviously be impacted by growth outlooks. Compared to 4Q21, the trio of banks also saw a bigger q-o-q increase in non-interest income in 1Q22, supported by wealth management and digitalisation initiatives. Combined non-interest income of the trio amounted to S$3.37 billion in 1Q22, up S$400 million from S$2.97 billion in 4Q21.

Daily Leveraged Certificates (DLCs) for Short-Term Trading Within the Singapore Banking Sector

The DLCs also provide a platform for spread trading between the banks, for investors that anticipate convergence or divergence in share prices. For instance between the session closes of Friday 15 July and Tuesday 19 July, the share price ratio spread of UOB to DBS reverted from one standard deviation below the mean share price ratio spread, back up to the mean. Specifically, at 0.8777 on 15 July, the share price ratio spread of UOB to DBS crossed back above the 0.8765 threshold that then represented one standard deviation below the rolling one-month mean, with the rolling mean at 0.8850. Over the ensuing two trading sessions, the price ratio spread of UOB to DBS continue to rise, reverting to just above the rolling one-month mean.

DLCs are financial instruments issued by third-party financial institutions and listed for trading in Singapore. 3 of the most traded Daily Leverage Certificates (DLCs) that track the performance of the trio of banks this month have been the 5x Long UOB (DHBW), the 5x Long DBS (DKBW) and the 5x Short DBS (DLDW).

Designed for Specified Investment Products (SIP)-qualified investors, DLCs seek to achieve short-term investment results that correspond to the daily magnified performance of the underlying stock.

On 19 July, the price ratio spread of UOB to DBS closed at 0.8835, with the rolling one-month mean at 0.8826. SIP-qualified investors that took even exposure in the 5x Long UOB (DHBW) DLC and the 5x Short DBS (DLDW) over the period would have booked a return of 1.5%, with the Long UOB (DHBW) DLC gaining 7.8% from 0.335 to 0.361, and the 5x Short DBS (DLDW) declining 4.8%, from 1.558 to 1.484. Note this is a theoretical return based on past prices and does not take into account transaction fees and taking the opposite positions over the three sessions would have generated a comparable loss. For a more comprehensive overview of DLCs, including risks, click here.

This article is provided by SGX My Gateway.

SGX My Gateway

SGX's investor education portal with market, product and investment information and events. Sign up now at to receive our investment updates and economic calendar.

This document is not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the SGX Group Companies) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.

SGX Stock / REIT Search